ArticleBreast cancer research and treatment2020
Treatment options for patients with HR+/HER2- advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy.
Joyce O'ShaughnessyPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.